Pizzuti Dana sold CRNX
November 3, 2025 · Form 4 insider transaction
Pizzuti Dana sold 100 shares of Crinetics Pharmaceuticals Inc at $43.27 per share, a transaction worth $4.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
100
Price
$43.27
Total value
$4.3K
InsiderPizzuti Dana
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 3, 2025
Filing dateNovember 5, 2025
Shares owned after66,270
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2025.; The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a sale price of $43.27 per share for 100 shares.